Barclays
TENX icon

Barclays’s Tenax Therapeutics TENX Stock Holding History

Barclays’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$267K Buy
+16,698
New +$226K ﹤0.01% 3528
2025
Q3 		– Sell
-11
Closed -$63 – 5727
2025
Q2 		$63 Buy
+11
New +$64 ﹤0.01% 5112
2019
Q4 		– Hold
0
– – – 6803
2019
Q3 		– Hold
0
– – – 7119
2019
Q2 		– Hold
0
– – – 7270
2019
Q1 		– Hold
0
– – – 7321
2018
Q4 		– Hold
0
– – – 7318
2014
Q2 		– Hold
0
– -$1K – 7801
2014
Q1 		– Sell
-1
Closed -$198K – 7486
2013
Q4 		$67K Buy
+1
New +$135K ﹤0.01% 5971

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Barclays's TENX Position: Q1 2026 in Review

Barclays opened a new position in Tenax Therapeutics (TENX) in Q1 2026: 16,698 shares worth $267K. The stake represents ﹤0.01% of the portfolio and ranks #3528 among its holdings. This is a return to the name: Barclays previously reported a position in TENX as recently as Q2 2025.

Barclays first reported a position in TENX in Q4 2013 and has held it in 3 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Barclays held 16,698 shares of Tenax Therapeutics worth $267K as of Q1 2026.
  • Tenax Therapeutics was a new Barclays position in Q1 2026.
  • Tenax Therapeutics made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3528 holding.
  • Barclays first reported a position in Tenax Therapeutics in Q4 2013 and has held it in 3 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.